MMP-9

MMP-9 분자 정보

영어 이름Matrix metalloproteinase 9시판 약물 수0
임상 약물 수3표적 별명Type V Collagenase,Gelatinase B,EC 3.4.24.35,MANDP2,Matrix Metalloproteinase 9,CLG4B,MMP9,Matrix Metallopeptidase 9,Matrix Metalloproteinase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),GELB,Matrix Metalloproteinase-9,92 KDa Type IV Collagenase,Macrophage Gelatinase,92 kDa gelatinase,MMP-9,Matrix Metallopeptidase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),EC:3.4.24.35,EC 3.4.24
최고 연구 개발 단계Phase 3 Clinical
영어 이름Matrix metalloproteinase 9
표적 별명Type V Collagenase,Gelatinase B,EC 3.4.24.35,MANDP2,Matrix Metalloproteinase 9,CLG4B,MMP9,Matrix Metallopeptidase 9,Matrix Metalloproteinase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),GELB,Matrix Metalloproteinase-9,92 KDa Type IV Collagenase,Macrophage Gelatinase,92 kDa gelatinase,MMP-9,Matrix Metallopeptidase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),EC:3.4.24.35,EC 3.4.24
시판 약물 수0
임상 약물 수3
최고 연구 개발 단계Phase 3 Clinical

MMP-9 제품 목록

  • 속성

    Protein (6)

  • 제품 라이브러리

    온라인 (6)

  • Human (4)Mouse (1)Cynomolgus (1)

  • 태그

    His Tag (6)

  • 마커

    Unconjugated (6)

MMP-9분자 배경

Matrix metallopeptidase 9 (MMP-9) is also known as 92 kDa type IV collagenase, 92 kDa gelatinase or gelatinase B (GELB), CLG4B, is secreted from neutrophils, macrophages, and a number of transformed cells, and is the most complex family member in terms of domain structure and regulation of its activity. . Structurally, MMP9 maybe be divided into five distinct domains: a prodomain which is cleaved upon activation, a gelatinbinding domain consisting of three contiguous fibronectin type II units, a catalytic domain containing the zinc binding site, a prolinerich linker region, and a carboxyl terminal hemopexinlike domain. This enzyme degrades various substrates including gelatin, collagen types IV and V, and elastin. MMP9 is involved in a variety of autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis, and be regarded as a potential therapeutic target.

MMP-9분자 별명

MMP9,CLG4B,GELB,MANDP2,Gelatinase B

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
AndecaliximabGS-5745Phase 3 ClinicalGilead IncArthritis, Rheumatoid; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Cystic Fibrosis; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Myositis Ossificans; Ossification, Heterotopic; Pancreatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Spinal Cord Injuries; Stomach Neoplasms
상세
AQU-005AQU-005; NMAQU-005; NM-AQU-005Phase 1 ClinicalAquilus PharmaceuticalsNeuralgia
상세
CALY-001CALY-001ClinicalCalypso Biotech BvCrohn Disease; Inflammatory Bowel Diseases
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호